The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: A double-blind randomized controlled clinical trial

European Journal of Clinical Nutrition

Volumn 69, Issue 8, 2015, Pages 891-895

  Rasekhi, H ^a   Karandish, M ^a   Jalali, M T ^a   Mohammad Shahi, M ^a   Zarei, M ^b   Saki, A ^a   Shahbazian, H ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; OSTEOCALCIN; PHYTOMENADIONE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CARBOXYLATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; ANALYSIS; BLOOD; DIETARY SUPPLEMENT; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PHYSIOLOGY; PREDIABETIC STATE; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OSTEOCALCIN; PREDIABETIC STATE; PREMENOPAUSE; VITAMIN K 1; YOUNG ADULT;

EID: 84938955918     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2015.17     Document Type: Article

References (29)

1. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469
2. Booth SL, Lichtenstein AH, O'Brien-Morse M, McKeown NM, Wood RJ, Saltzman E et al. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr 2001; 74: 783-790
3. Beulens JW, Van Der AD, Grobbee DE, Sluijs I, Spijkerman AM, Van Der Schouw YT. Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes. Diabetes Care 2010; 33: 1699-1705
4. Pan Y, Jackson RT. Dietary phylloquinone intakes and metabolic syndrome in US young adults. J Am Coll Nutr 2009; 28: 369-379
5. Yoshida M, Booth SL, Meigs JB, Saltzman E, Jacques PF. Phylloquinone intake, insulin sensitivity, and glycemic status in men and women. Am J Clin Nutr 2008; 88: 210-215
6. Kanazawa I, Yamaguchi T, Tada Y, Yamauchi M, Yano S, Sugimoto T. Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone 2011; 48: 720-725
7. Hwang YC, Jeong IK, Ahn KJ, Chung HY. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-Aged male subjects. Diabetes Metab Res Rev 2009; 25: 768-772
8. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr 2010; 92: 1528-1532
9. Yoshida M, Jacques PF, Meigs JB, Saltzman E, Shea MK, Gundberg C et al. Effect of vitamin K supplementation on insulin resistance in older men and women. Diabetes Care 2008; 31: 2092-2096
10. Abseyi N, Siklar Z, Berberoglu M, Hacihamdioglu B, Savas Erdeve S, Ocal G. Relationships between osteocalcin, glucose metabolism, and adiponectin in obese children: Is there crosstalk between bone tissue and glucose metabolism? J Clin Res Pediatr Endocrinol 2012; 4: 182-188
11. Lu C, Ivaska KK, Alen M, Wang Q, Tormakangas T, Xu L et al. Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women. J Clin Endocrinol Metab 2012; 97: 4106-4114
12. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: 62S-69SS.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
14. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM et al. Validation of the insulin sensitivity index (ISI(0, 120)): comparison with other measures. Diabetes Res Clin Pract 2000; 47: 177-184
15. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 2010; 33: e93
16. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270
17. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011; 22: 187-194
18. Prats-Puig A, Mas-Parareda M, Riera-Perez E, Gonzalez-Forcadell D, Mier C, Mallol-Guisset M et al. Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 2010; 33: 661-663
19. Chen X, Wu Y, Liu L, Tian H, Yu X. Osteocalcin is inversely associated with glucose levels in middle-Aged Tibetan men with different degrees of glucose tolerance. Diabetes Metab Res Rev 2013; 30: 476-482
20. Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E et al. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int 2012; 23: 761-770
21. Fernandez-Real JM, Izquierdo M, Ortega F, Gorostiaga E, Gomez-Ambrosi J, Moreno-Navarrete JM et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009; 94: 237-245
22. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 45-49
23. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009; 24: 785-791
24. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009; 94: 827-832
25. Pollock NK, Bernard PJ, Gower BA, Gundberg CM, Wenger K, Misra S et al. Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J Clin Endocrinol Metab 2011; 96: E1092-E1099
26. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 1997; 65: 779-784
27. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr., Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005; 54: 3252-3257
28. Choi HJ, Yu J, Choi H, An JH, Kim SW, Park KS et al. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care 2011; 34: e147
29. Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LY et al. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZONPFT, and FREEDOM trials. J Bone Miner Res 2013; 28: 1348-1354